skip to Main Content

Findorff's Response to the Coronavirus (COVID-19)

Catalent expansion news in madison

‘Unprecedented’ pace of COVID-19 drug development pushing Madison companies to expand

Spurred on by the push to end the COVID-19 pandemic, Catalent Biologics is rapidly expanding its Madison facilities and staff to account for increased production of substances used by various pharmaceutical companies around the world.

Back To Top
Joint Our Email List
  • Join Our Email List

  • Subscribe to Updates